Article
The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
10 Mar 2022
Abstract excerpt
The AlkB family of Fe (II) and α-ketoglutarate-dependent dioxygenases works by removing alkyl substituents from alkylation-damaged nucleic acid bases through oxidative dealkylation, subsequently affecting tumor progression and patient prognosis. However, the specific roles of the AlkB family in Glioblastoma remain to be elucidated. By taking advantage of the abundant bioinformatics databases, such as GEPIA2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
